HYBRID EVENT: Join us in person in Orlando, Florida, USA or attend virtually from anywhere.

8th Edition of Global Conference on

Addiction Medicine, Behavioral Health and Psychiatry

October 21-23, 2027 | Orlando, Florida, USA

Role of Neurotransmitters in Addiction

Role of Neurotransmitters in Addiction

Neurotransmitters such as dopamine, serotonin, and gamma-aminobutyric acid (GABA) play pivotal roles in addiction. Dopamine, often linked to the brain's reward system, is excessively released during substance use, reinforcing the behavior and creating a cycle of dependency. Serotonin dysregulation can lead to mood disturbances, increasing susceptibility to addiction. GABA, a neurotransmitter responsible for calming the brain, becomes imbalanced, leading to heightened anxiety and withdrawal symptoms. These disruptions alter neural pathways, making it challenging to break free from addiction. Recovery often focuses on restoring neurotransmitter balance through pharmacological interventions and behavioral therapies. Understanding the role of neurotransmitters sheds light on addiction's complexity, emphasizing the importance of tailored treatment strategies that address these biochemical changes for sustainable recovery.

Committee Members
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2027 - Christopher Ashton

Christopher Ashton

TeDDs on Chapel, Centre for Recovery, Canada
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2027 - John J Giordano

John J Giordano

Life Enhancement Recovery Center, United States
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2027 - Sam Vaknin

Sam Vaknin

Commonwealth Institute of Advanced Professional Studies (CIAPS), United Kingdom
Tags

Submit your abstract Today

Whatsapp